What is the current Virbac market capitalization?
The current market capitalization of Virbac is 3.02 B EUR.
Virbac Market capitalization 2025
Virbac Market capitalization
3.02 B EUR
Ticker
VIRP.PA
ISIN
FR0000031577
WKN
874929
In 2025, Virbac's market cap stood at 3.02 B EUR, a 4.47% increase from the 2.89 B EUR market cap in the previous year.
The Virbac Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2024 | 2.91 |
| 2023 | 2.36 |
| 2022 | 2.8 |
| 2021 | 2.62 |
| 2020 | 1.68 |
| 2019 | 1.44 |
| 2018 | 1.06 |
| 2017 | 1.19 |
| 2016 | 1.36 |
| 2015 | 1.73 |
| 2014 | 1.4 |
| 2013 | 1.32 |
| 2012 | 1.16 |
| 2011 | - |
| 2010 | - |
| 2009 | - |
| 2008 | - |
| 2007 | - |
| 2006 | - |
| 2005 | - |
Virbac Aktienanalyse
What does Virbac do?
Virbac SA is a French company specializing in animal medicines and care products. The company was founded in 1968 by Pierre Richard Dick, who studied veterinary medicine at the École nationale vétérinaire d'Alfort and gained experience as a veterinarian. Since its founding, Virbac SA has been headquartered near Carros, France and operates worldwide. The business model of Virbac SA is to offer a wide range of products to veterinarians and pet owners, aiming to ensure optimal health, care, and quality of life for their pets. This includes everything from vaccines, diagnostics, and medications to grooming products that veterinarians and pet owners need to ensure optimal pet healthcare. Virbac SA has five main business areas, namely livestock, pets, horses, hygiene products, and specialties. The livestock sector includes products such as feed additives and antiparasitics tailored to the specific needs of cattle, pigs, poultry, and fish. In the pets sector, Virbac SA offers products specifically tailored to dogs, cats, birds, and other pets. This includes both disease prevention and treatment products. In the horse sector, the company offers products for the maintenance, care, and health of horses. Another division of Virbac SA is hygiene products. The company offers a wide portfolio of products and solutions that support both veterinarians and pet owners in ensuring the health and care of animals. This ranges from infection control products to animal-specific shampoos and grooming items. The specialties sector, on the other hand, includes specialized products such as targeted diagnostics, therapeutics, and dietary supplements. The constant focus on research and development also leads to innovative product launches that consistently meet the highest quality standards. An example of this is the scientifically developed dental hygiene product line that improves both the oral health and breath quality of dogs and cats. For this, Virbac SA also receives awards from the Veterinary Center for Clinical Medicine in Munich. Through a systematic international expansion strategy, Virbac SA is now present in more than 100 countries. The company employs over 4,800 people worldwide and achieved a turnover of 954 million euros in 2019. Overall, Virbac SA stands for consistently high product quality and a strong customer orientation. With a combination of expertise and extensive scientific research and development, particularly in the field of animal health and care, the company is an important player in the global animal medicine manufacturing market. Virbac ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Virbac's Market Capitalization
Virbac's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Virbac's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Virbac's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Virbac’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Virbac stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Virbac.
How has the market capitalization of Virbac developed in recent years?
The market capitalization of Virbac has increased/decreased by 4.47% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Virbac?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Virbac?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Virbac have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Virbac pay?
Over the past 12 months, Virbac paid a dividend of 1.32 EUR . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Virbac is expected to pay a dividend of 1.5 EUR.
What is the dividend yield of Virbac?
The current dividend yield of Virbac is 0.37 %.
When does Virbac pay dividends?
Virbac pays a quarterly dividend. This is distributed in the months of July, July, July, July.
How secure is the dividend of Virbac?
Virbac paid dividends every year for the past 0 years.
What is the dividend of Virbac?
For the upcoming 12 months, dividends amounting to 1.5 EUR are expected. This corresponds to a dividend yield of 0.42 %.
In which sector is Virbac located?
Virbac is assigned to the 'Health' sector.
Wann musste ich die Aktien von Virbac kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Virbac from 6/26/2025 amounting to 1.45 EUR, you needed to have the stock in your portfolio before the ex-date on 6/24/2025.
When did Virbac pay the last dividend?
The last dividend was paid out on 6/26/2025.
What was the dividend of Virbac in the year 2024?
In the year 2024, Virbac distributed 1.32 EUR as dividends.
In which currency does Virbac pay out the dividend?
The dividends of Virbac are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Virbac stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Virbac
Our stock analysis for Virbac Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Virbac Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
